Ultrahuman has launched Blood Vision, a blood-testing platform in the US that assesses susceptibility to certain cancers and evaluates cholesterol, blood health, glucose, and other markers for longevity. The platform involves users providing eight to ten vials of blood to be tested for over 120 markers. Results are delivered through an AI-powered clinician via the Ultrahuman app. Additionally, a mid-year assessment covers over 60 markers, exemplifying the trend of collaboration between medical facilities and wearable technology brands in health initiatives.
Blood Vision takes blood tests to a whole new level and assesses blood markers 'in the context of lifestyle factors and longevity,' according to Ultrahuman.
Users visit a medical lab and provide eight to ten vials of blood, which is then assessed for over 120 blood markers covering glucose, cholesterol, proteins, and more.
The results are summarized and delivered by an AI-powered clinician through the Ultrahuman app, enhancing the user's insight into their health.
Collaboration between medical facilities and wearable brands, such as Ultrahuman, is a common trend in the health technology field.
Collection
[
|
...
]